Wolfe Research Initiates Coverage on Alpine Immune Sciences (NASDAQ:ALPN)
Research analysts at Wolfe Research initiated coverage on shares of Alpine Immune Sciences (NASDAQ:ALPN – Get Free Report) in a report released on Thursday, Briefing.com reports. The firm set an “outperform” rating and a $44.00 price target on the biotechnology company’s stock. Wolfe Research’s price target points to a potential upside of 51.05% from the […]